Pharmaceutics · 2020 · 38 citations · 31 references
PharmacyPharmaceuticsPharmacologyBioavailabilityDrug DeliveryOral Drug DeliveryDrug Delivery SystemsLipid-based Drug Delivery SystemsLipid-based Oral FormulationsOral NanocarriersSelf-emulsifying Drug Delivery SystemsSurfactantsIonic LiquidsLow SolubilityNonionic SurfactantsOral Drug BioavailabilityOral Drug Delivery FormulationsOral Drug Delivery SystemsSelf-nanoemulsifying Drug Delivery SystemsVisceral Leishmaniasis
Amphotericin B (AmpB), one of the most commonly used agents in the treatment of severe fungal infections and life-threatening parasitic diseases such as visceral Leishmaniasis, has a negligible oral bioavailability, primarily due to a low solubility and permeability. To develop an oral formulation, medium chain triglycerides and nonionic surfactants in a self-nano-emulsifying drug delivery system (SNEDDS) containing AmpB were combined with room temperature ionic liquids (RTILs) of imidazolium. The presence of ionic liquids significantly enhanced the solubility of AmpB, exhibited a low toxicity and increased the transport of AmpB across Caco-2 cell monolayers. The combination of RTILs with a lipid formulation might be a promising strategy to improve the oral bioavailability of AmpB.
31
Formulation of self-emulsifying drug delivery systems
Colin W. Pouton · Advanced Drug Delivery Reviews · 1997 · 622 citations
K Balakumar, Chellan Vijaya Raghavan, Natarajan Tamil selvan et al. · Colloids and Surfaces B Biointerfaces · 2013 · 326 citations
Designing ionic liquids: the chemical structure role in the toxicity
Sónia P. M. Ventura, Ana M. M. Gonçalves, Tânia E. Sintra et al. · Ecotoxicology · 2012 · 264 citations · Full text
Pharmacy, Chemistry, Toxicology +10